Real-time enrollment status for this castration-sensitive prostate carcinoma clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 9:25 AM UTC
| NCT Number | NCT06931340 |
| Recruiting Status | Recruiting |
| Condition | Castration-Sensitive Prostate Carcinoma |
| Phase | PHASE3 |
| Target Enrollment | 1,260 participants |
| Active Locations | 200 sites in the US |
| Sponsor | Alliance for Clinical Trials in Oncology |
| Last Updated on CT.gov | August 5, 2026 (3 weeks ago) |
As of August 27, 2026: Clinical trial NCT06931340 is currently recruiting participants. This phase3 study for castration-sensitive prostate carcinoma is actively seeking new participants at 200 locations across the United States. The study is sponsored by Alliance for Clinical Trials in Oncology. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06931340 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 200 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06931340 was last updated 3 weeks ago (August 5, 2026). HelloStudys verifies this status automatically.